Abstract
Intermittent exogenous parathyroid hormone (PTH) is a potent osteoanabolic agent used for the treatment of severe osteoporosis. Two molecules of recombinant PTH are commercially available: the full-length PTH (PTH 1–84) and teriparatide (PTH 1–34). We present the first report of PTH-induced mild, asymptomatic, normochromic normocytic anemia in a postmenopausal woman treated sequentially with PTH 1–84 and PTH 1–34. Anemia was more pronounced with PTH 1–84 compared to PTH 1–34 and was reversed with each regimen discontinuation. We suggest monitoring of hematocrit and hemoglobin in PTH-treated patients, especially when PTH 1–84 is used.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boxer M, Ellman L, Geller R, Wang CA (1977) Anemia in primary hyperparathyroidism. Arch Intern Med 137:588–593
McGonigle RJ, Wallin JD, Husserl F, Deftos LJ, Rice JC, O’Neill WJ, Fisher JW (1984) Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. J Lab Clin Med 104:1016–1026
Meytes D, Bogin E, Ma A, Dukes PP, Massry SG (1981) Effect of parathyroid hormone on erythropoiesis. J Clin Invest 67:1263–1269
Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM (2008) Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery (St. Louis) 144:915–918
Greenspan SA, Bone HA, Ettinger MA, Hanley DA, Lindsay R, Zanchetta JA, Blosch CA, Mathisen AA, Morris SA, Marriott TA (2007) Effect of recombinant human parathyroid hormone (1–84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326–339
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441
Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW (1983) High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med 102:613–620
Komatsuda A, Hirokawa M, Haseyama T, Horiuchi T, Wakui H, Imai H, Miura AB (1998) Human parathyroid hormone does not influence human erythropoiesis in vitro. Nephrol Dial Transplant 13:2088–2091
Meytes D, Shacked N, Blum M, Ramot B (1990) Effect of excess parathyroid hormone on human bone marrow fibroblasts. Nephron 55:6–9
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Anastasilakis, A.D., Savvides, M., Polyzos, S.A. et al. Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone. J Bone Miner Metab 28, 108–110 (2010). https://doi.org/10.1007/s00774-009-0105-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-009-0105-3